Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death

Cell - Tập 149 - Trang 1060-1072 - 2012
Scott J. Dixon1, Kathryn M. Lemberg1, Michael R. Lamprecht2, Rachid Skouta1, Eleina M. Zaitsev1, Caroline E. Gleason1, Darpan N. Patel1, Andras J. Bauer1, Alexandra M. Cantley1, Wan Seok Yang1, Barclay Morrison2, Brent R. Stockwell1,3,4
1Department of Biological Sciences, Columbia University, 550 West 120th Street, Northwest Corner Building, MC 4846, New York, NY 10027, USA
2Department of Biomedical Engineering, Columbia University, 550 West 120th Street, Northwest Corner Building, MC 4846, New York, NY 10027, USA
3Department of Chemistry, Columbia University, 550 West 120th Street, Northwest Corner Building, MC 4846, New York, NY 10027, USA
4Howard Hughes Medical Institute, Columbia University, 550 West 120th Street, Northwest Corner Building, MC 4846, New York, NY 10027, USA

Tài liệu tham khảo

Banjac, 2008, The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death, Oncogene, 27, 1618, 10.1038/sj.onc.1210796 Bergsbaken, 2009, Pyroptosis: host cell death and inflammation, Nat. Rev. Microbiol., 7, 99, 10.1038/nrmicro2070 Cater, 2007, Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels, J. Neurochem., 101, 434, 10.1111/j.1471-4159.2006.04379.x Cheah, 2006, NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1, Neuron, 51, 431, 10.1016/j.neuron.2006.07.011 Choi, 1988, Glutamate neurotoxicity and diseases of the nervous system, Neuron, 1, 623, 10.1016/0896-6273(88)90162-6 Christofferson, 2010, Necroptosis as an alternative form of programmed cell death, Curr. Opin. Cell Biol., 22, 263, 10.1016/j.ceb.2009.12.003 Dolma, 2003, Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells, Cancer Cell, 3, 285, 10.1016/S1535-6108(03)00050-3 Duce, 2010, Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease, Cell, 142, 857, 10.1016/j.cell.2010.08.014 Fuchs, 2011, Programmed cell death in animal development and disease, Cell, 147, 742, 10.1016/j.cell.2011.10.033 Gout, 2001, Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug, Leukemia, 15, 1633, 10.1038/sj.leu.2402238 Guo, 2008, Identification of a small molecule with synthetic lethality for K-ras and protein kinase C iota, Cancer Res., 68, 7403, 10.1158/0008-5472.CAN-08-1449 Ishii, 1981, Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine, J. Biol. Chem., 256, 12387, 10.1016/S0021-9258(18)43284-X Jacobson, 1995, Programmed cell death and Bcl-2 protection in very low oxygen, Nature, 374, 814, 10.1038/374814a0 Kamata, 2009, Roles of Nox1 and other Nox isoforms in cancer development, Cancer Sci., 100, 1382, 10.1111/j.1349-7006.2009.01207.x Kanai, 2003, Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity, J. Toxicol. Sci., 28, 1, 10.2131/jts.28.1 Laleu, 2010, First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis, J. Med. Chem., 53, 7715, 10.1021/jm100773e Lei, 2012, Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export, Nat. Med., 18, 291, 10.1038/nm.2613 Li, 1997, A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion, Neuron, 19, 453, 10.1016/S0896-6273(00)80953-8 Lo, 2008, The xc- cystine/glutamate antiporter: a mediator of pancreatic cancer growth with a role in drug resistance, Br. J. Cancer, 99, 464, 10.1038/sj.bjc.6604485 Lossi, 2009, Cell death and proliferation in acute slices and organotypic cultures of mammalian CNS, Prog. Neurobiol., 88, 221, 10.1016/j.pneurobio.2009.01.002 Macarron, 2011, Impact of high-throughput screening in biomedical research, Nat. Rev. Drug Discov., 10, 188, 10.1038/nrd3368 Morrison, 2002, L-arginyl-3,4-spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission, Br. J. Pharmacol., 137, 1255, 10.1038/sj.bjp.0704986 Mullen, 2011, Reductive carboxylation supports growth in tumour cells with defective mitochondria, Nature, 481, 385, 10.1038/nature10642 Murphy, 1989, Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress, Neuron, 2, 1547, 10.1016/0896-6273(89)90043-3 Ni Chonghaile, 2011, Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy, Science, 334, 1129, 10.1126/science.1206727 Noraberg, 2005, Organotypic hippocampal slice cultures for studies of brain damage, neuroprotection and neurorepair, Curr. Drug Targets CNS Neurol. Disord., 4, 435, 10.2174/1568007054546108 Pagliarini, 2008, A mitochondrial protein compendium elucidates complex I disease biology, Cell, 134, 112, 10.1016/j.cell.2008.06.016 Pinnix, 2010, Ferroportin and iron regulation in breast cancer progression and prognosis, Sci. Transl. Med., 2, 43ra56, 10.1126/scitranslmed.3001127 Raj, 2011, Selective killing of cancer cells by a small molecule targeting the stress response to ROS, Nature, 475, 231, 10.1038/nature10167 Ramanathan, 2009, Direct control of mitochondrial function by mTOR, Proc. Natl. Acad. Sci. USA, 106, 22229, 10.1073/pnas.0912074106 Ratan, 1994, Oxidative stress induces apoptosis in embryonic cortical neurons, J. Neurochem., 62, 376, 10.1046/j.1471-4159.1994.62010376.x Salahudeen, 2009, An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis, Science, 326, 722, 10.1126/science.1176326 Sato, 1999, Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins, J. Biol. Chem., 274, 11455, 10.1074/jbc.274.17.11455 Shaw, 2011, Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress, Proc. Natl. Acad. Sci. USA, 108, 8773, 10.1073/pnas.1105941108 Sundstrom, 2005, Organotypic cultures as tools for functional screening in the CNS, Drug Discov. Today, 10, 993, 10.1016/S1359-6446(05)03502-6 Tan, 1998, The regulation of reactive oxygen species production during programmed cell death, J. Cell Biol., 141, 1423, 10.1083/jcb.141.6.1423 Thompson, 1995, Apoptosis in the pathogenesis and treatment of disease, Science, 267, 1456, 10.1126/science.7878464 Trachootham, 2006, Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate, Cancer Cell, 10, 241, 10.1016/j.ccr.2006.08.009 Vashisht, 2009, Control of iron homeostasis by an iron-regulated ubiquitin ligase, Science, 326, 718, 10.1126/science.1176333 Vigil, 2010, Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy?, Nat. Rev. Cancer, 10, 842, 10.1038/nrc2960 Wang, 2009, Poly(ADP-ribose) signals to mitochondrial AIF: a key event in parthanatos, Exp. Neurol., 218, 193, 10.1016/j.expneurol.2009.03.020 Watkins, 2007, Evidence for 26 distinct acyl-coenzyme A synthetase genes in the human genome, J. Lipid Res., 48, 2736, 10.1194/jlr.M700378-JLR200 Wise, 2008, Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc. Natl. Acad. Sci. USA, 105, 18782, 10.1073/pnas.0810199105 Wolpaw, 2011, Modulatory profiling identifies mechanisms of small molecule-induced cell death, Proc. Natl. Acad. Sci. USA, 108, E771, 10.1073/pnas.1106149108 Yagoda, 2007, RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels, Nature, 447, 864, 10.1038/nature05859 Yang, 2008, Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells, Chem. Biol., 15, 234, 10.1016/j.chembiol.2008.02.010 Yonezawa, 1996, Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffusible glial factor, J. Neurochem., 67, 566, 10.1046/j.1471-4159.1996.67020566.x Blois, M.S. (1958). Antioxidant determinations by the use of a stable free radical. Nature 181, 1199–1200. Cater, H.L., Gitterman, D., Davis, S.M., Benham, C.D., Morrison, B., III, and Sundstrom, L.E. (2007). Stretch-induced injury in organotypic hippocampal slice cultures reproduces in vivo post-traumatic neurodegeneration: role of glutamate receptors and voltage-dependent calcium channels. J. Neurochem. 101, 434–447. Chung, N., Zhang, X.D., Kreamer, A., Locco, L., Kuan, P.F., Bartz, S., Linsley, P.S., Ferrer, M., and Strulovici, B. (2008). Median absolute deviation to improve hit selection for genome-scale RNAi screens. J. Biomol. Screen. 13, 149–158. Ishida, T., Suzuki, T., Hirashima, S., Mizutani, K., Yoshida, A., Ando, I., Ikeda, S., Adachi, T., and Hashimoto, H. (2006). Benzimidazole inhibitors of hepatitis C virus NS5B polymerase: identification of 2-[(4-diarylmethoxy)phenyl]-benzimidazole. Bioorg. Med. Chem. Lett. 16, 1859–1863. Kanai, Y., and Endou, H. (2003). Functional properties of multispecific amino acid transporters and their implications to transporter-mediated toxicity. J. Toxicol. Sci. 28, 1–17. Lipinski, C.A., Lombardo, F., Dominy, B.W., and Feeney, P.J. (2001). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46, 3–26. Moffat, J., Grueneberg, D.A., Yang, X., Kim, S.Y., Kloepfer, A.M., Hinkle, G., Piqani, B., Eisenhaure, T.M., Luo, B., Grenier, J.K., et al. (2006). A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell 124, 1283–1298. Morrison, B., III, Pringle, A.K., McManus, T., Ellard, J., Bradley, M., Signorelli, F., Iannotti, F., and Sundstrom, L.E. (2002). L-arginyl-3,4-spermidine is neuroprotective in several in vitro models of neurodegeneration and in vivo ischaemia without suppressing synaptic transmission. Br. J. Pharmacol. 137, 1255–1268. Ramanathan, A., and Schreiber, S.L. (2009). Direct control of mitochondrial function by mTOR. Proc. Natl. Acad. Sci. USA 106, 22229–22232. Sanchez, M., Galy, B., Schwanhaeusser, B., Blake, J., Bähr-Ivacevic, T., Benes, V., Selbach, M., Muckenthaler, M.U., and Hentze, M.W. (2011). Iron regulatory protein-1 and -2: transcriptome-wide definition of binding mRNAs and shaping of the cellular proteome by iron regulatory proteins. Blood 118, e168–e179. Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A.J., Yang, W.S., Fridman, D.J., Wolpaw, A.J., Smukste, I., Peltier, J.M., Boniface, J.J., et al. (2007). RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels. Nature 447, 864–868. Yang, W.S., and Stockwell, B.R. (2008). Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. Chem. Biol. 15, 234–245.